Business Wire·Mar 4, 2026, 8:30 AM ET

QT Imaging Names Renowned Breast Cancer Researcher Dr. Mary Yamashita as Medical Advisor

QT Imaging Holdings, Inc. (NASDAQ: QTI) announced that Mary W. Yamashita, MD will serve as its Medical Advisor.
Dr. Yamashita will provide strategic support in clinical interpretation standards, structured reporting frameworks, training architecture, & reader study design.
Her current roles include Section Chief of the Breast Imaging division at USC Keck School of Medicine, Medical Director of Mammography at USC Verdugo Hills Hospital Breast Center, & Medical Director at the USC Arcadia Breast Center.
CEO Raluca Dinu, PhD stated that Dr. Yamashita's appointment underscores the company's commitment to clinical excellence & the evidence-based deployment of its breast imaging solution.
Dr. Yamashita expressed excitement to help advance QT Imaging's radiation-free, 3D breast imaging solution while prioritizing accuracy, safety, & patient care.
Dr. Yamashita holds a medical degree from USC Keck School of Medicine, completed a diagnostic radiology residency at UC Irvine, & is board certified by the American Board of Radiology.
QT Imaging is a medical device company developing imaging systems using low frequency sound waves, including its Breast Acoustic CT™ trademarked technology.
The press release includes standard forward-looking statements regarding future development, commercialization, & financial projections with associated risks & uncertainties.